Alpha Cognition Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACOG research report →
About the company
Alpha Cognition Inc. , a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
- CEO
- Michael E. McFadden
- IPO
- 2024
- Employees
- 71
- HQ
- Grapevine, BC, US
Price Chart
- Market Cap
- $122.54M
- P/E
- -6.83
- P/S
- 11.32
- P/B
- 2.99
- EV/EBITDA
- -2.53
- Div Yield
- 0.00%
- Gross Margin
- 84.42%
- Op Margin
- -249.97%
- Net Margin
- -232.24%
- ROE
- -54.13%
- ROIC
- -42.40%
- Revenue
- $10.22M · 0.00%
- Net Income
- $-20,669,875 · -41.22%
- EPS
- $-1.17 · 42.08%
- Op Income
- $-22,660,689
- FCF YoY
- -165.65%
- 52W High
- $11.54
- 52W Low
- $4.50
- 50D MA
- $6.25
- 200D MA
- $6.20
- Beta
- 2.33
- Avg Volume
- 43.93K
Get TickerSpark's AI analysis on ACOG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 26, 26 | Opaleye Management Inc. | buy | 152,336 |
| Jun 25, 26 | Opaleye Management Inc. | buy | 197 |
| Jun 15, 26 | Opaleye Management Inc. | buy | 4,550 |
| Jun 12, 26 | Opaleye Management Inc. | buy | 273 |
| Jun 11, 26 | Opaleye Management Inc. | buy | 2,862 |
| Jun 10, 26 | Opaleye Management Inc. | buy | 5,872 |
| Jun 9, 26 | Opaleye Management Inc. | buy | 24,856 |
| Jun 5, 26 | Opaleye Management Inc. | buy | 10,054 |
| May 29, 26 | Opaleye Management Inc. | buy | 70,577 |
| May 28, 26 | Opaleye Management Inc. | buy | 2,000 |
Our ACOG coverage
Recent articles, reports, and earnings notes.
No research on ACOG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACOG report →Similar companies
Peers in the same neighborhood.